,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,155,1,1,,132863,3048,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the rad50 strain,Other,,
1,157,1,1,,132863,3048,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mec2-1 strain,Other,,
2,161,1,1,,132863,3048,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the sgs1 mgt1 strain,Other,,
3,165,1,1,,132863,3048,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the cln2 rad14 strain,Other,,
4,167,1,1,,132863,3048,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the bub3 strain,Other,,
5,175,1,1,,132863,3048,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mlh1 rad18 strain,Other,,
6,328,1,1,,132863,3048,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
7,330,1,1,,132863,3048,Inconclusive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice,Other,,
8,421,1,3,,17389922,3048,Inactive,,,,,Cell Viability - BJ,Confirmatory,,
9,426,1,2,,17389922,3048,Inconclusive,,,,,Cell Viability - Jurkat,Confirmatory,,
10,427,1,1,,17389922,3048,Inactive,,,,,Cell Viability - Hek293,Confirmatory,,
11,433,1,1,,17389922,3048,Inactive,,,,,Cell Viability - HepG2,Confirmatory,,
12,434,1,2,,17389922,3048,Inactive,,,,,Cell Viability - MRC5,Confirmatory,,
13,435,1,2,,17389922,3048,Inactive,,,,,Cell Viability - SK-N-SH,Confirmatory,,
14,445,3,1,,17389922,3048,Inconclusive,10092619.0,4792.0,,,IkB Signaling,Confirmatory,,
15,530,1,1,,17389922,3048,Inactive,2499604.0,26414.0,,,JNK3 AlphaScreen Assay,Confirmatory,,
16,540,1,1,,17389922,3048,Inconclusive,,,,,Cell Viability - N2a,Confirmatory,,
17,541,1,1,,17389922,3048,Inactive,,,,,Cell Viability - NIH 3T3,Confirmatory,,
18,542,1,1,,17389922,3048,Inactive,,,,,Cell Viability - HUV-EC-C,Confirmatory,,
19,543,1,1,,17389922,3048,Inactive,,,,,Cell Viability - H-4-II-E,Confirmatory,,
20,544,2,1,,17389922,3048,Inactive,,,,,Cell Viability - SH-SY5Y,Confirmatory,,
21,545,1,1,,17389922,3048,Inactive,,,,,Cell Viability - Renal Proximal Tubule,Confirmatory,,
22,546,1,1,,17389922,3048,Inconclusive,,,,,Cell Viability - Mesenchymal,Confirmatory,,
23,584,1,3,,17389922,3048,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent),Confirmatory,,
24,585,1,4,,17389922,3048,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent),Confirmatory,,
25,595,1,3,,17389922,3048,Inactive,,,,,qHTS Assay for Disrupters of an Hsp90 Co-Chaperone Interaction,Confirmatory,,
26,596,1,2,,17389922,3048,Inactive,92096784.0,4137.0,,,qHTS Assay for Tau Filament Binding,Confirmatory,,
27,603,1,2,,17389922,3048,Inactive,,,,,qHTS Assay for Inhibitors of DNA Polymerase III Holoenzyme System,Confirmatory,,
28,605,1,2,,17389922,3048,Inactive,84028058.0,,,,qHTS Assay for Inhibitors of YjeE,Confirmatory,,
29,654,1,1,,17389922,3048,Inactive,,,,,Cellular Toxicity (caspase-3) HepG2,Confirmatory,,
30,655,1,1,,17389922,3048,Inactive,,,,,Cellular Toxicity (caspase-3) Jurkat,Confirmatory,,
31,656,1,1,,17389922,3048,Inactive,,,,,Cellular Toxicity (caspase-3) HUV-EC-C,Confirmatory,,
32,657,1,1,,17389922,3048,Inactive,,,,,Cellular Toxicity (caspase-3) SHSY5Y,Confirmatory,,
33,658,1,1,,17389922,3048,Inactive,,,,,Cellular Toxicity (caspase-3) BJ,Confirmatory,,
34,659,1,1,,17389922,3048,Inactive,,,,,Cellular Toxicity (caspase-3) MRC-5,Confirmatory,,
35,660,1,1,,17389922,3048,Inactive,,,,,Cellular Toxicity (caspase-3) Mesangial,Confirmatory,,
36,661,1,1,,17389922,3048,Inactive,,,,,Cellular Toxicity (caspase-3) SK-N-SH,Confirmatory,,
37,662,1,1,,17389922,3048,Inconclusive,,,,,Cell signaling CRE-BLA (Fsk stim),Confirmatory,,
38,663,1,1,,17389922,3048,Inactive,,,,,Cellular Toxicity (caspase-3) H-4-II-E,Confirmatory,,
39,664,1,1,,17389922,3048,Inactive,,,,,Cellular Toxicity (caspase-3) Hek293,Confirmatory,,
40,665,1,1,,17389922,3048,Inactive,,,,,Cellular Toxicity (caspase-3) N2a,Confirmatory,,
41,666,1,1,,17389922,3048,Inactive,,,,,Cellular Toxicity (caspase-3) NIH 3T3,Confirmatory,,
42,667,1,1,,17389922,3048,Inactive,,,,,Cellular Toxicity (caspase-3) Renal Proximal Tubule,Confirmatory,,
43,875,1,2,,17389922,3048,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Green Fluorophore),Confirmatory,,
44,880,2,1,,17389922,3048,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
45,880,2,1,,17389922,3048,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
46,880,2,1,,26747345,3048,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
47,880,2,1,,26747345,3048,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
48,881,2,2,,17389922,3048,Inactive,317373425.0,247.0,,Potency,qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2),Confirmatory,,
49,884,1,2,,17389922,3048,Inconclusive,13435386.0,1576.0,12.5893,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4,Confirmatory,,
50,885,1,2,,17389922,3048,Inactive,13435386.0,1576.0,12.5893,Potency,qHTS Assay for Activators of Cytochrome P450 3A4,Confirmatory,,
51,886,1,2,,17389922,3048,Inactive,122921310.0,,,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
52,886,1,2,,17389922,3048,Inactive,122921311.0,,,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
53,887,1,2,,17389922,3048,Inactive,1832253.0,246.0,,Potency,qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase),Confirmatory,,
54,889,1,3,,17389922,3048,Inactive,1730092.0,840.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-7,Confirmatory,,
55,892,1,2,,17389922,3048,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Red Fluorophore),Confirmatory,,
56,893,1,2,,17389922,3048,Inactive,122921310.0,,,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
57,893,1,2,,17389922,3048,Inactive,122921311.0,,,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
58,894,2,1,,17389922,3048,Inactive,31542939.0,3248.0,,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
59,894,2,1,,26747345,3048,Inactive,31542939.0,3248.0,,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
60,900,1,3,,17389922,3048,Inactive,15431328.0,834.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1,Confirmatory,,
61,902,1,2,,17389922,3048,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature,Confirmatory,,
62,910,1,2,,17389922,3048,Inactive,4504349.0,3043.0,,Potency,Confirmation and Secondary Assay for Modulators of Hemoglobin Beta Chain Splicing at IVS2 654 locus,Confirmatory,,
63,912,1,2,,17389922,3048,Inconclusive,21392848.0,,31.6228,Potency,qHTS Assay for Anthrax Lethal Toxin Internalization,Confirmatory,,
64,921,1,2,,17389922,3048,Inconclusive,,,39.8107,Potency,Cell Viability - LYMP2-001,Confirmatory,,
65,923,1,2,,17389922,3048,Inactive,,,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1: Spectroscopic Profiling in AFC Spectral Region,Confirmatory,,
66,924,1,2,,17389922,3048,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature,Confirmatory,,
67,925,1,2,,17389922,3048,Inactive,4504349.0,3043.0,,Potency,qHTS Assay for Modulators of Hemoglobin Beta Chain Splicing,Confirmatory,,
68,926,1,2,,17389922,3048,Active,38016895.0,7253.0,25.1189,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor,Confirmatory,,
69,927,1,3,,17389922,3048,Inactive,188528692.0,9099.0,,Potency,qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a,Confirmatory,,
70,930,1,2,,17389922,3048,Inactive,4504349.0,3043.0,,Potency,Confirmation and Secondary Assay for Modulators of Hemoglobin Beta Chain Splicing at IVS2 705 locus,Confirmatory,,
71,938,1,2,,17389922,3048,Inactive,38016895.0,7253.0,,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293,Confirmatory,,
72,940,1,2,,26613405,3048,Inactive,31881630.0,5732.0,,,Modulators of the EP2 prostaglandin E2 receptor - Primary Screening,Screening,,
73,946,1,2,,17389922,3048,Active,,,31.6228,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-001 - Dead Cells,Confirmatory,,
74,947,1,2,,17389922,3048,Active,,,15.8489,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-001 - Live Cells,Confirmatory,,
75,948,1,2,,17389922,3048,Active,,,12.5893,Potency,Cell Viability - LYMP1-002 - Assay at 16 hr,Confirmatory,,
76,955,1,2,,17389922,3048,Inconclusive,,,3.9811,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-002 - Live Cells,Confirmatory,,
77,960,1,2,,17389922,3048,Active,,,19.9526,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-002 - Dead Cells,Confirmatory,,
78,961,1,2,,17389922,3048,Active,,,10.0,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-003 - Dead Cells,Confirmatory,,
79,962,1,2,,17389922,3048,Active,,,12.5893,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-003 - Live Cells,Confirmatory,,
80,963,1,2,,17389922,3048,Active,,,25.1189,Potency,Cell Viability - LYMP1-003 - Assay at 24 hr,Confirmatory,,
81,964,1,2,,17389922,3048,Active,,,10.0,Potency,Cell Viability - LYMP1-003 - Assay at 40 hr,Confirmatory,,
82,965,1,2,,17389922,3048,Active,,,25.1189,Potency,Cell Viability - LYMP2-003,Confirmatory,,
83,966,1,2,,17389922,3048,Active,,,19.9526,Potency,Cell Viability - LYMP2-004,Confirmatory,,
84,967,1,2,,17389922,3048,Active,,,19.9526,Potency,Cell Viability - LYMP2-005,Confirmatory,,
85,968,1,2,,17389922,3048,Inconclusive,,,39.8107,Potency,Cell Viability - LYMP2-009,Confirmatory,,
86,969,1,2,,17389922,3048,Active,,,39.8107,Potency,Cell Viability - LYMP2-011,Confirmatory,,
87,970,1,2,,17389922,3048,Active,,,39.8107,Potency,Cell Viability - LYMP2-013,Confirmatory,,
88,971,1,2,,17389922,3048,Active,,,39.8107,Potency,Cell Viability - LYMP2-015,Confirmatory,,
89,972,1,2,,17389922,3048,Inconclusive,,,39.8107,Potency,Cell Viability - LYMP2-017,Confirmatory,,
90,973,1,2,,17389922,3048,Inconclusive,,,39.8107,Potency,Cell Viability - LYMP2-019,Confirmatory,,
91,974,1,2,,17389922,3048,Active,,,39.8107,Potency,Cell Viability - LYMP2-021,Confirmatory,,
92,975,1,2,,17389922,3048,Active,,,39.8107,Potency,Cell Viability - LYMP2-023,Confirmatory,,
93,976,1,2,,17389922,3048,Active,,,50.1187,Potency,Cell Viability - LYMP2-025,Confirmatory,,
94,977,1,2,,17389922,3048,Active,,,31.6228,Potency,Cell Viability - LYMP2-002,Confirmatory,,
95,978,1,2,,17389922,3048,Active,,,31.6228,Potency,Cell Viability - LYMP2-006,Confirmatory,,
96,979,1,2,,17389922,3048,Active,,,31.6228,Potency,Cell Viability - LYMP2-007,Confirmatory,,
97,980,1,2,,17389922,3048,Inconclusive,,,39.8107,Potency,Cell Viability - LYMP2-008,Confirmatory,,
98,981,1,2,,17389922,3048,Active,,,50.1187,Potency,Cell Viability - LYMP2-010,Confirmatory,,
99,982,1,2,,17389922,3048,Active,,,39.8107,Potency,Cell Viability - LYMP2-012,Confirmatory,,
100,983,1,2,,17389922,3048,Inconclusive,,,39.8107,Potency,Cell Viability - LYMP2-014,Confirmatory,,
101,984,1,2,,17389922,3048,Active,,,50.1187,Potency,Cell Viability - LYMP2-016,Confirmatory,,
102,985,1,2,,17389922,3048,Active,,,39.8107,Potency,Cell Viability - LYMP2-018,Confirmatory,,
103,986,1,2,,17389922,3048,Active,,,31.6228,Potency,Cell Viability - LYMP2-020,Confirmatory,,
104,987,1,2,,17389922,3048,Active,,,39.8107,Potency,Cell Viability - LYMP2-022,Confirmatory,,
105,988,1,2,,17389922,3048,Active,,,39.8107,Potency,Cell Viability - LYMP2-024,Confirmatory,,
106,989,1,2,,17389922,3048,Active,,,39.8107,Potency,Cell Viability - LYMP2-026,Confirmatory,,
107,993,1,2,,17389922,3048,Active,,,12.5893,Potency,Cell Viability - LYMP1-002 - Assay at 24 hr,Confirmatory,,
108,994,1,2,,17389922,3048,Active,,,12.5893,Potency,Cell Viability - LYMP1-002 - Assay at 40 hr,Confirmatory,,
109,995,1,2,,17389922,3048,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay,Confirmatory,,
110,1030,2,1,,17389922,3048,Inactive,30582681.0,216.0,,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
111,1030,2,1,,26747345,3048,Inactive,30582681.0,216.0,,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
112,1379,1,2,,26747345,3048,Inactive,1669525.0,,,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
113,1422,1,1,,26613405,3048,Inactive,31881630.0,5732.0,,,Inhibitors of the EP2 Prostaglandin E2 Receptor - Primary Screen,Screening,,
114,1452,1,1,,17389922,3048,Inactive,154426292.0,239.0,,Potency,qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase),Confirmatory,,
115,1454,1,1,,26747345,3048,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF,Confirmatory,,
116,1457,1,1,,17389922,3048,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
117,1457,1,1,,26747345,3048,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
118,1458,1,1,,17389922,3048,Inactive,10937869.0,6607.0,,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
119,1458,1,1,,26747345,3048,Inactive,10937869.0,6607.0,,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
120,1460,1,3,,26747345,3048,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
121,1463,1,1,,26747345,3048,Inactive,,,,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
122,1467,1,3,,26747345,3048,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5.,Confirmatory,,
123,1468,1,1,,26747345,3048,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
124,1469,1,1,,17389922,3048,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
125,1469,1,1,,26747345,3048,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
126,1471,2,1,,17389922,3048,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
127,1471,2,1,,26747345,3048,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
128,1476,2,1,,17389922,3048,Inconclusive,281307097.0,,7.9433,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
129,1476,2,1,,26747345,3048,Active,281307097.0,,1.5849,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
130,1477,1,1,,17389922,3048,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
131,1478,2,1,,17389922,3048,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
132,1478,2,1,,26747345,3048,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
133,1479,1,2,,17389922,3048,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
134,1479,1,2,,26747345,3048,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
135,1487,1,1,,26747345,3048,Inactive,27436948.0,4000.0,,Potency,qHTS Assay for Modulators of Lamin A Splicing,Confirmatory,,
136,1490,2,1,,26747345,3048,Inactive,10954339.0,,,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
137,1519,1,3,,26747345,3048,Inactive,,,,Potency,qHTS Assay for Lipid Storage Modulators,Confirmatory,,
138,1580,1,1,,8149181,3048,Inconclusive,,,,,Screen for compounds that inhibit mitochondrial permeability transition (MitoPT),Other,,
139,1581,1,1,,8149181,3048,Inconclusive,,,,,Screen of Compounds to Block PAR4 - aPKC Interaction for Treatment of Neurodegeneration (Par4_PKC),Other,,
140,1582,1,1,,8149181,3048,Inconclusive,,,,,Yeast cell-based screen for Novel HDAC inhibitors using a PHO84-LacZ reporter gene (PHO84),Other,,
141,1583,1,1,,8149181,3048,Unspecified,,,,,Assay to identify inhibitors of polyglutamine-induced caspase-3 activation (CASP3),Other,,
142,1584,1,1,,8149181,3048,Inconclusive,,,,,Screen for compounds that inhibit in vitro mutant huntingtin aggregation (QA1),Other,,
143,1585,1,1,,8149181,3048,Inconclusive,,,,,"Screen for compounds that inhibit the ability of solid phase synthetic polyglutamine aggregates to elongate by incorporating solution-phase biotin-tagged, monomeric polyglutamine (QA3)",Other,,
144,1586,1,1,,8149181,3048,Inconclusive,,,,,A 2-Hybrid Test for Interactions Between Polyglutamine-Containing Proteins in the Yeast Nucleus  (Qn2Hy),Other,,
145,1587,1,1,,8149181,3048,Inconclusive,,,,,Screen for compounds that increase the expression of EAAT-2 in rat spinal cord organotypic slice cultures (X4_EAAT2),Other,,
146,1588,1,1,,8149181,3048,Inconclusive,,,,,Screen for compounds that reduce polyglutamine aggregation as measured by turbidity (QTHIO),Other,,
147,1589,1,1,,8149181,3048,Inconclusive,,,,,Screen for compounds that reduce polyglutamine (polyQ) inclusions in nerve growth factor (NGF)-treated PC12 cells (SDS),Other,,
148,1590,1,1,,8149181,3048,Inconclusive,,,,,Cellular toxicity caused by inducible expressing of N-terminal huntingtin with expanded ployglutamine repeat (Htt-N63-148Q) in PC12 cells (ROSShtt),Other,,
149,1593,1,1,,8149181,3048,Unspecified,,,,,Yeast cell-based screen for compounds that suppress polyglutamine aggregation in vivo (75Q-TubU),Other,,
150,1594,1,1,,8149181,3048,Inconclusive,,,,,Screen for compounds that decrease glutamate induced motor neuron death measured by TUNEL staining for DNA degradation (MNGlu),Other,,
151,1595,1,1,,8149181,3048,Inconclusive,,,,,Suppression of Polyglutamine Toxicity in Whole Organism Drosophila Model of SCA1 (SCA1FLYe),Other,,
152,1596,1,1,,8149181,3048,Inconclusive,,,,,Protection from expanded polyglutamine huntingtin toxicity in PC12 cells (LDH100),Other,,
153,1597,1,1,,8149181,3048,Inconclusive,,,,,Suppression of Polyglutamine Toxicity in Whole Organism Drosophila Model of SCA1 (SCA1FLYp),Other,,
154,1598,1,1,,8149181,3048,Inconclusive,,,,,Screen for compounds that selectively increase SMN2 splicing relative to SMN1 splicing (SMNLUC),Other,,
155,1599,1,1,,8149181,3048,Unspecified,,,,,"Screen for compounds that correct neuronal dysfunction without cell death as induced by the expression of polyglutamine-expanded, N-terminal huntingtin in C. elegans mechanosensory neurons (HDELENEU)",Other,,
156,1600,1,1,,8149181,3048,Inconclusive,,,,,Yeast Assay for Parkinson&apos;s Disease (YAPD),Other,,
157,1601,1,1,,8149181,3048,Inconclusive,,,,,Screen for compounds that suppress mutant SOD1-mediated cell death (mSODtox),Other,,
158,1602,1,1,,8149181,3048,Inconclusive,,,,,Screen for compounds that attenuate mutant SOD1 toxicity (mSOD1),Other,,
159,1603,1,1,,8149181,3048,Unspecified,,,,,Screen for compounds that selectively inhibit cytochrome c release from purified mitochondria (CytoCRel),Other,,
160,1604,1,1,,8149181,3048,Unspecified,,,,,Screen for compounds that inhibit polyglutamine induced protein aggregation (AGREG),Other,,
161,1605,1,1,,8149181,3048,Unspecified,,,,,Screening of compounds showing protective effect against cell death induced by familial amyotrophic lateral sclerosis (FALS)-linked mutantsuperoxide dismutase 1 (SOD1) (ALSOD1),Other,,
162,1606,1,1,,8149181,3048,Inconclusive,,,,,Protection from expanded polyglutamine huntingtin toxicity in PC12 cells (LDH20),Other,,
163,1607,1,1,,8149181,3048,Inconclusive,,,,,Screen for compounds that promote the turnover of an expanded polyglutamine androgen receptor (AR112GFP),Other,,
164,1608,1,1,,8149181,3048,Inconclusive,,,,,Protection from expanded polyglutamine huntingtin toxicity in PC12 cells (LDH016),Other,,
165,1609,1,1,,8149181,3048,Inconclusive,,,,,Protection from expanded polyglutamine huntingtin toxicity in PC12 cells (LDH08),Other,,
166,1610,1,1,,8149181,3048,Inconclusive,,,,,Protection from expanded polyglutamine huntingtin toxicity in PC12 cells,Other,,
167,1612,1,1,,8149181,3048,Unspecified,,,,,Screen for compounds that increase glutamate transport activity in MN-1 cell line (GluUPTAKE),Other,,
168,1613,1,1,,8149181,3048,Unspecified,,,,,Screen for compounds that inhibit protein aggregation formed by mutant SOD1 (GFPSOD1),Other,,
169,1614,1,1,,8149181,3048,Unspecified,,,,,Screen for compounds that reduce polyglutamine (polyQ) inclusions in nerve growth factor (NGF)-treated PC12 cells (GFPQ80),Other,,
170,1616,1,1,,8149181,3048,Unspecified,,,,,Yeast cell-based screen for compounds that suppress polyglutamine aggregation in vivo (75Q-TubH),Other,,
171,1688,1,1,,26747345,3048,Inactive,90903231.0,3064.0,,Potency,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP),Confirmatory,,
172,1766,1,1,,26747345,3048,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
173,1766,1,1,,26747345,3048,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
174,1768,1,1,,26747345,3048,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
175,1768,1,1,,26747345,3048,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
176,1865,1,1,,26747345,3048,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
177,1948,1,1,,17389922,3048,Inactive,,,,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
178,1948,1,1,,26747345,3048,Inactive,,,,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
179,2101,1,1,,17389922,3048,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
180,2101,1,1,,26747345,3048,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
181,2107,1,1,,17389922,3048,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
182,2107,1,1,,26747345,3048,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
183,2112,1,1,,17389922,3048,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
184,2112,1,1,,26747345,3048,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
185,2120,1,1,,17389922,3048,Inactive,32879895.0,3091.0,,Potency,qHTS Assay for Identification of Small Molecule Inducers of Hypoxia Response,Confirmatory,,
186,2147,1,1,,26747345,3048,Inactive,221046486.0,,,Potency,qHTS Assay for Inhibitors of  Human Jumonji Domain Containing 2E (JMJD2E),Confirmatory,,
187,2451,1,2,,26747345,3048,Inactive,122920737.0,,,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
188,2472,1,2,,26747345,3048,Inactive,7669492.0,2597.0,,,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen",Screening,,
189,2517,2,1,,17389922,3048,Inactive,6980812.0,,,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
190,2528,1,2,,26747345,3048,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
191,2546,1,1,,17389922,3048,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
192,2546,1,1,,26747345,3048,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
193,2549,1,1,,17389922,3048,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
194,2549,1,1,,26747345,3048,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
195,2551,1,1,,17389922,3048,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
196,2551,1,1,,26747345,3048,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
197,2662,2,1,,26747345,3048,Inactive,56550039.0,4297.0,,Potency,qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction,Confirmatory,,
198,485281,1,1,,26747345,3048,Inactive,254220970.0,,,Potency,qHTS Assay for Identification of Novel General Anesthetics,Confirmatory,,
199,485290,1,1,,17389922,3048,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
200,485290,1,1,,26747345,3048,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
201,492961,1,1,,26747345,3048,Inactive,72386991.0,3656265.0,,Potency,qHTS Assay to Find Inhibitors of T. brucei phosphofructokinase: hit validation,Confirmatory,,
202,492967,1,2,,99301787,3048,Inactive,47566732.0,,,,A screen for compounds that inhibit the CapD enzyme of Bacillus anthracis,Other,,
203,493162,1,2,,99301787,3048,Inactive,335756.0,,,,A screen for compounds that inhibit processive DNA synthesis of vaccinia virus,Other,,
204,504327,1,1,,26747345,3048,Inactive,153791535.0,2648.0,,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
205,504332,1,1,,26747345,3048,Inactive,168985070.0,,,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Confirmatory,,
206,504749,1,3,,26747345,3048,Unspecified,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
207,504749,1,3,1.0,26747345,3048,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
208,504749,1,3,2.0,26747345,3048,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
209,504749,1,3,3.0,26747345,3048,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
210,504749,1,3,4.0,26747345,3048,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
211,504749,1,3,5.0,26747345,3048,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
212,504749,1,3,6.0,26747345,3048,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
213,504749,1,3,7.0,26747345,3048,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
214,504749,1,3,8.0,26747345,3048,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
215,504749,1,3,9.0,26747345,3048,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
216,504749,1,3,10.0,26747345,3048,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
217,504749,1,3,11.0,26747345,3048,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
218,504749,1,3,12.0,26747345,3048,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
219,504749,1,3,13.0,26747345,3048,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
220,504749,1,3,14.0,26747345,3048,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
221,504749,1,3,15.0,26747345,3048,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
222,504749,1,3,16.0,26747345,3048,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
223,504749,1,3,17.0,26747345,3048,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
224,504749,1,3,18.0,26747345,3048,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
225,504749,1,3,19.0,26747345,3048,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
226,504749,1,3,20.0,26747345,3048,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
227,504749,1,3,21.0,26747345,3048,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
228,504749,1,3,22.0,26747345,3048,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
229,504749,1,3,23.0,26747345,3048,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
230,504749,1,3,24.0,26747345,3048,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
231,504749,1,3,25.0,26747345,3048,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
232,504749,1,3,26.0,26747345,3048,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
233,504749,1,3,27.0,26747345,3048,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
234,504749,1,3,28.0,26747345,3048,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
235,504749,1,3,29.0,26747345,3048,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
236,504749,1,3,30.0,26747345,3048,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
237,504749,1,3,31.0,26747345,3048,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
238,504749,1,3,32.0,26747345,3048,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
239,504749,1,3,33.0,26747345,3048,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
240,504749,1,3,34.0,26747345,3048,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
241,504749,1,3,35.0,26747345,3048,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
242,504749,1,3,36.0,26747345,3048,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
243,504749,1,3,37.0,26747345,3048,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
244,504749,1,3,38.0,26747345,3048,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
245,504749,1,3,39.0,26747345,3048,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
246,504749,1,3,40.0,26747345,3048,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
247,504749,1,3,41.0,26747345,3048,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
248,504749,1,3,42.0,26747345,3048,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
249,504749,1,3,43.0,26747345,3048,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
250,504749,1,3,44.0,26747345,3048,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
251,504749,1,3,45.0,26747345,3048,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
252,504749,1,3,46.0,26747345,3048,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
253,504749,1,3,47.0,26747345,3048,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
254,504749,1,3,48.0,26747345,3048,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
255,504749,1,3,49.0,26747345,3048,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
256,504749,1,3,50.0,26747345,3048,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
257,504749,1,3,51.0,26747345,3048,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
258,504749,1,3,52.0,26747345,3048,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
259,504749,1,3,53.0,26747345,3048,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
260,504749,1,3,54.0,26747345,3048,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
261,504749,1,3,55.0,26747345,3048,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
262,504749,1,3,56.0,26747345,3048,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
263,504749,1,3,57.0,26747345,3048,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
264,504749,1,3,58.0,26747345,3048,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
265,504749,1,3,59.0,26747345,3048,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
266,504749,1,3,60.0,26747345,3048,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
267,504749,1,3,61.0,26747345,3048,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
268,504832,1,1,,26747345,3048,Inactive,,,,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation",Confirmatory,,
269,504834,1,1,,26747345,3048,Inactive,,,,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation",Confirmatory,,
270,504847,1,1,,26747345,3048,Inconclusive,63054845.0,7421.0,79.4328,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
271,504865,1,1,,26747345,3048,Inconclusive,118600387.0,7398.0,63.0957,Potency,Inhibitors of USP1/UAF1: Pilot qHTS,Confirmatory,,
272,588513,1,1,,17389922,3048,Inactive,348019627.0,2099.0,,Potency,qHTS assay for small molecule antagonists of estrogen receptor alpha signaling,Confirmatory,,
273,588514,1,1,,17389922,3048,Inconclusive,348019627.0,2099.0,,Potency,qHTS assay for small molecule agonists of estrogen receptor alpha signaling,Confirmatory,,
274,588515,1,1,,17389922,3048,Inactive,124375976.0,367.0,,Potency,qHTS assay for small molecule agonists of androgen receptor signaling,Confirmatory,,
275,588516,1,1,,17389922,3048,Inactive,124375976.0,367.0,,Potency,qHTS assay for small molecule antagonists of androgen receptor signaling,Confirmatory,,
276,588526,1,1,,17389922,3048,Inconclusive,325495553.0,9971.0,,Potency,qHTS assay for small molecule antagonists of farnesoid X receptor signaling,Confirmatory,,
277,588527,1,1,,17389922,3048,Inactive,325495553.0,9971.0,,Potency,qHTS assay for small molecule agonists of farnesoid X receptor signaling,Confirmatory,,
278,588532,1,1,,17389922,3048,Inactive,311348376.0,2908.0,,Potency,qHTS assay for small molecule agonists of glucocorticoid receptor signaling,Confirmatory,,
279,588533,1,1,,17389922,3048,Inactive,311348376.0,2908.0,,Potency,qHTS assay for small molecule antagonists of glucocorticoid receptor signaling,Confirmatory,,
280,588534,1,1,,17389922,3048,Inactive,216409690.0,5467.0,,Potency,qHTS assay for small molecule agonists of peroxisome proliferator-activated receptor delta signaling,Confirmatory,,
281,588535,1,1,,17389922,3048,Inconclusive,216409690.0,5467.0,50.1187,Potency,qHTS assay for small molecule antagonists of peroxisome proliferator-activated receptor delta signaling,Confirmatory,,
282,588536,1,1,,17389922,3048,Inactive,216409692.0,5468.0,,Potency,qHTS assay for small molecule agonists of peroxisome proliferator-activated receptor gamma signaling,Confirmatory,,
283,588537,1,1,,17389922,3048,Inconclusive,216409692.0,5468.0,44.6684,Potency,qHTS assay for small molecule antagonists of peroxisome proliferator-activated receptor gamma signaling,Confirmatory,,
284,588541,1,1,,17389922,3048,Inactive,216409708.0,7421.0,,Potency,qHTS assay for small molecule antagonists of vitamin D receptor signaling,Confirmatory,,
285,588543,1,1,,17389922,3048,Inactive,216409708.0,7421.0,,Potency,qHTS assay for small molecule agonists of vitamin D receptor signaling,Confirmatory,,
286,588544,1,1,,17389922,3048,Inconclusive,325495497.0,6256.0,,Potency,qHTS assay for small molecule agonists of retinoid X receptor alpha signaling,Confirmatory,,
287,588545,1,1,,17389922,3048,Inactive,189491771.0,7068.0,,Potency,qHTS assay for small molecule agonists of thyroid hormone receptor beta signaling,Confirmatory,,
288,588546,1,1,,17389922,3048,Inconclusive,325495497.0,6256.0,,Potency,qHTS assay for small molecule antagonists of retinoid X receptor alpha signaling,Confirmatory,,
289,588547,1,1,,17389922,3048,Inactive,189491771.0,7068.0,,Potency,qHTS assay for small molecule antagonists of thyroid hormone receptor beta signaling,Confirmatory,,
290,588579,1,1,,26747345,3048,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
291,588812,1,1,,17389922,3048,Unspecified,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
292,588812,1,1,1.0,17389922,3048,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
293,588812,1,1,2.0,17389922,3048,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
294,588812,1,1,3.0,17389922,3048,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
295,588812,1,1,4.0,17389922,3048,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
296,588812,1,1,5.0,17389922,3048,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
297,588812,1,1,6.0,17389922,3048,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
298,588812,1,1,7.0,17389922,3048,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
299,588812,1,1,8.0,17389922,3048,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
300,588812,1,1,9.0,17389922,3048,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
301,588812,1,1,10.0,17389922,3048,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
302,588812,1,1,11.0,17389922,3048,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
303,588812,1,1,12.0,17389922,3048,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
304,588812,1,1,13.0,17389922,3048,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
305,588812,1,1,14.0,17389922,3048,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
306,588812,1,1,15.0,17389922,3048,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
307,588812,1,1,16.0,17389922,3048,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
308,588812,1,1,17.0,17389922,3048,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
309,588812,1,1,18.0,17389922,3048,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
310,588812,1,1,19.0,17389922,3048,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
311,588812,1,1,20.0,17389922,3048,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
312,588812,1,1,21.0,17389922,3048,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
313,588812,1,1,22.0,17389922,3048,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
314,588812,1,1,23.0,17389922,3048,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
315,588812,1,1,24.0,17389922,3048,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
316,588812,1,1,25.0,17389922,3048,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
317,588812,1,1,26.0,17389922,3048,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
318,588812,1,1,27.0,17389922,3048,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
319,588812,1,1,28.0,17389922,3048,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
320,588812,1,1,29.0,17389922,3048,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
321,588812,1,1,30.0,17389922,3048,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
322,588812,1,1,31.0,17389922,3048,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
323,588812,1,1,32.0,17389922,3048,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
324,588812,1,1,33.0,17389922,3048,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
325,588812,1,1,34.0,17389922,3048,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
326,588812,1,1,35.0,17389922,3048,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
327,588812,1,1,36.0,17389922,3048,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
328,588812,1,1,37.0,17389922,3048,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
329,588812,1,1,38.0,17389922,3048,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
330,588812,1,1,39.0,17389922,3048,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
331,588812,1,1,40.0,17389922,3048,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
332,588812,1,1,41.0,17389922,3048,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
333,588812,1,1,42.0,17389922,3048,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
334,588812,1,1,43.0,17389922,3048,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
335,588812,1,1,44.0,17389922,3048,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
336,588812,1,1,45.0,17389922,3048,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
337,588812,1,1,46.0,17389922,3048,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
338,588812,1,1,47.0,17389922,3048,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
339,588812,1,1,48.0,17389922,3048,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
340,588812,1,1,49.0,17389922,3048,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
341,588812,1,1,50.0,17389922,3048,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
342,588812,1,1,51.0,17389922,3048,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
343,588812,1,1,52.0,17389922,3048,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
344,588812,1,1,53.0,17389922,3048,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
345,588812,1,1,54.0,17389922,3048,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
346,588812,1,1,55.0,17389922,3048,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
347,588812,1,1,56.0,17389922,3048,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
348,588812,1,1,57.0,17389922,3048,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
349,588812,1,1,58.0,17389922,3048,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
350,588812,1,1,59.0,17389922,3048,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
351,588812,1,1,60.0,17389922,3048,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
352,588812,1,1,61.0,17389922,3048,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
353,588812,1,1,62.0,17389922,3048,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
354,588812,1,1,63.0,17389922,3048,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
355,588812,1,1,64.0,17389922,3048,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
356,588812,1,1,65.0,17389922,3048,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
357,588812,1,1,66.0,17389922,3048,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
358,588812,1,1,67.0,17389922,3048,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
359,588812,1,1,68.0,17389922,3048,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
360,588812,1,1,69.0,17389922,3048,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
361,588812,1,1,70.0,17389922,3048,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
362,588812,1,1,71.0,17389922,3048,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
363,588812,1,1,72.0,17389922,3048,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
364,588812,1,1,73.0,17389922,3048,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
365,588812,1,1,74.0,17389922,3048,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
366,588812,1,1,75.0,17389922,3048,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
367,588812,1,1,76.0,17389922,3048,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
368,588812,1,1,77.0,17389922,3048,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
369,588812,1,1,78.0,17389922,3048,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
370,588812,1,1,79.0,17389922,3048,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
371,588812,1,1,80.0,17389922,3048,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
372,588812,1,1,81.0,17389922,3048,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
373,588813,1,1,,17389922,3048,Unspecified,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
374,588813,1,1,1.0,17389922,3048,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
375,588813,1,1,2.0,17389922,3048,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
376,588813,1,1,3.0,17389922,3048,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
377,588813,1,1,4.0,17389922,3048,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
378,588813,1,1,5.0,17389922,3048,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
379,588813,1,1,6.0,17389922,3048,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
380,588813,1,1,7.0,17389922,3048,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
381,588813,1,1,8.0,17389922,3048,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
382,588813,1,1,9.0,17389922,3048,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
383,588813,1,1,10.0,17389922,3048,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
384,588813,1,1,11.0,17389922,3048,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
385,588813,1,1,12.0,17389922,3048,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
386,588813,1,1,13.0,17389922,3048,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
387,588813,1,1,14.0,17389922,3048,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
388,588813,1,1,15.0,17389922,3048,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
389,588813,1,1,16.0,17389922,3048,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
390,588813,1,1,17.0,17389922,3048,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
391,588813,1,1,18.0,17389922,3048,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
392,588813,1,1,19.0,17389922,3048,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
393,588813,1,1,20.0,17389922,3048,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
394,588813,1,1,21.0,17389922,3048,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
395,588813,1,1,22.0,17389922,3048,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
396,588813,1,1,23.0,17389922,3048,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
397,588813,1,1,24.0,17389922,3048,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
398,588813,1,1,25.0,17389922,3048,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
399,588813,1,1,26.0,17389922,3048,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
400,588813,1,1,27.0,17389922,3048,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
401,588813,1,1,28.0,17389922,3048,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
402,588813,1,1,29.0,17389922,3048,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
403,588813,1,1,30.0,17389922,3048,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
404,588813,1,1,31.0,17389922,3048,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
405,588813,1,1,32.0,17389922,3048,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
406,588813,1,1,33.0,17389922,3048,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
407,588813,1,1,34.0,17389922,3048,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
408,588813,1,1,35.0,17389922,3048,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
409,588813,1,1,36.0,17389922,3048,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
410,588813,1,1,37.0,17389922,3048,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
411,588813,1,1,38.0,17389922,3048,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
412,588813,1,1,39.0,17389922,3048,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
413,588813,1,1,40.0,17389922,3048,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
414,588813,1,1,41.0,17389922,3048,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
415,588813,1,1,42.0,17389922,3048,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
416,588813,1,1,43.0,17389922,3048,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
417,588813,1,1,44.0,17389922,3048,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
418,588813,1,1,45.0,17389922,3048,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
419,588813,1,1,46.0,17389922,3048,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
420,588813,1,1,47.0,17389922,3048,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
421,588813,1,1,48.0,17389922,3048,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
422,588813,1,1,49.0,17389922,3048,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
423,588813,1,1,50.0,17389922,3048,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
424,588813,1,1,51.0,17389922,3048,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
425,588813,1,1,52.0,17389922,3048,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
426,588813,1,1,53.0,17389922,3048,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
427,588813,1,1,54.0,17389922,3048,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
428,588813,1,1,55.0,17389922,3048,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
429,588813,1,1,56.0,17389922,3048,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
430,588813,1,1,57.0,17389922,3048,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
431,588813,1,1,58.0,17389922,3048,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
432,588813,1,1,59.0,17389922,3048,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
433,588813,1,1,60.0,17389922,3048,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
434,588813,1,1,61.0,17389922,3048,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
435,588813,1,1,62.0,17389922,3048,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
436,588813,1,1,63.0,17389922,3048,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
437,588813,1,1,64.0,17389922,3048,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
438,588813,1,1,65.0,17389922,3048,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
439,588813,1,1,66.0,17389922,3048,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
440,588813,1,1,67.0,17389922,3048,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
441,588813,1,1,68.0,17389922,3048,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
442,588813,1,1,69.0,17389922,3048,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
443,588813,1,1,70.0,17389922,3048,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
444,588813,1,1,71.0,17389922,3048,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
445,588813,1,1,72.0,17389922,3048,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
446,588813,1,1,73.0,17389922,3048,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
447,588813,1,1,74.0,17389922,3048,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
448,588813,1,1,75.0,17389922,3048,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
449,588813,1,1,76.0,17389922,3048,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
450,588813,1,1,77.0,17389922,3048,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
451,588813,1,1,78.0,17389922,3048,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
452,588813,1,1,79.0,17389922,3048,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
453,588813,1,1,80.0,17389922,3048,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
454,588813,1,1,81.0,17389922,3048,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
455,588834,2,1,,17389922,3048,Active,325651834.0,3757.0,35.4813,Potency,qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity,Confirmatory,,
456,602332,1,1,,26747345,3048,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
457,624030,1,2,,26747345,3048,Inactive,160794.0,,,Potency,Biochemical firefly luciferase enzyme assay for NPC,Confirmatory,,
458,624031,1,2,,26747345,3048,Inactive,,,,Potency,S16 Schwann cell viability assay (CellTiter-Glo assay),Confirmatory,,
459,624032,1,2,,26747345,3048,Inactive,8393992.0,24660.0,,Potency,S16 Schwann cell PMP22 intronic element firefly luciferase assay,Confirmatory,,
460,624044,1,2,,26747345,3048,Inactive,8393992.0,24660.0,,Potency,S16 Schwann cell PMP22 intronic element beta-lactamase assay,Confirmatory,,
461,624170,1,1,,26747345,3048,Inactive,71051501.0,2744.0,,Potency,qHTS for Inhibitors of Glutaminase (GLS),Confirmatory,,
462,624172,1,1,,26747345,3048,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Agonists,Confirmatory,,
463,624173,1,3,,26747345,3048,Inactive,62359610.0,,,Potency,qHTS of Trypanosoma Brucei Inhibitors,Confirmatory,,
464,624263,1,1,,26747345,3048,Inactive,3063388.0,5071.0,,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
465,624263,1,1,,26747345,3048,Inactive,37183032.0,,,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
466,624296,1,1,,26747345,3048,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells.,Confirmatory,,
467,624297,1,1,,26747345,3048,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells.,Confirmatory,,
468,651741,1,1,,17389922,3048,Active,20149576.0,4780.0,42.1632,Potency,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
469,651743,1,1,,17389922,3048,Inconclusive,269849759.0,7157.0,44.6684,Potency,qHTS assay for small molecule activators of the p53 signaling pathway,Confirmatory,,
470,651749,1,1,,17389922,3048,Inactive,34577122.0,4790.0,,Potency,qHTS assay for small molecule activators of the nuclear factor-kappa B (NF-kB) signaling pathway,Confirmatory,,
471,651751,1,1,,17389922,3048,Active,5702233.0,84385.0,50.1187,Potency,qHTS assay for small molecule activators of the rat pregnane X receptor (rPXR) signaling pathway,Confirmatory,,
472,651754,1,1,,17389922,3048,Inconclusive,,,42.1632,Potency,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - 1 hr assay,Confirmatory,,
473,651755,1,1,,17389922,3048,Inactive,,,,Potency,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - 5 hr assay,Confirmatory,,
474,651757,1,1,,17389922,3048,Inactive,25952111.0,7124.0,,Potency,qHTS assay to identify small molecules that stimulate Tumor Necrosis Factor-alpha (TNF-alpha) secretion,Confirmatory,,
475,651758,1,1,,17389922,3048,Inconclusive,186368.0,3576.0,14.9601,Potency,qHTS assay to identify small molecules that stimulate interleukin-8 (IL-8) secretion,Confirmatory,,
476,651777,1,1,,17389922,3048,Inactive,51095037.0,196.0,,Potency,qHTS assay for environmental chemicals that activate the Aryl hydrocarbon Receptor (AhR) signaling pathway,Confirmatory,,
477,651778,1,1,,17389922,3048,Inactive,3041727.0,5465.0,,Potency,qHTS assay for small molecule agonists of the peroxisome proliferator-activated receptor alpha (PPARalpha) signaling pathway,Confirmatory,,
478,651802,1,1,,17389922,3048,Active,49066040.0,6097.0,13.3332,Potency,qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
479,651838,1,1,,17389922,3048,Unspecified,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
480,651838,1,1,1.0,17389922,3048,Inconclusive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
481,651838,1,1,2.0,17389922,3048,Inconclusive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
482,651838,1,1,3.0,17389922,3048,Inconclusive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
483,651838,1,1,4.0,17389922,3048,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
484,651838,1,1,5.0,17389922,3048,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
485,651838,1,1,6.0,17389922,3048,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
486,651838,1,1,7.0,17389922,3048,Inconclusive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
487,651838,1,1,8.0,17389922,3048,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
488,720636,1,1,,17389922,3048,Inactive,20149576.0,4780.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway measured by Nrf2-dependant transcriptional activity,Confirmatory,,
489,720652,1,1,,17389922,3048,Inconclusive,,,37.578,Potency-Replicate_1,qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
490,720653,1,1,,17389922,3048,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway measured by Nrf2-dependant transcriptional activity - cell viability counter screen,Confirmatory,,
491,720659,1,1,,17389922,3048,Active,325495557.0,8856.0,12.5893,Potency-Replicate_1,qHTS assay for small molecule activators of the human pregnane X receptor (PXR) signaling pathway,Confirmatory,,
492,743288,1,1,,17389922,3048,Inactive,,,,Potency,qHTS assay for cell viability of HEK293 cells,Confirmatory,,
493,743292,1,1,,17389922,3048,Inactive,,,,Potency,qHTS assay for cell viability of the p53RE-bla HCT-116 cell line,Confirmatory,,
494,977599,1,1,,174494671,3048,Unspecified,,,,,Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM,Other,23571415.0,
495,977602,1,2,,174494671,3048,Unspecified,,,,,Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM,Other,23571415.0,
496,1159580,2,1,,268736368,3048,Inactive,,,,,"The chemical genetic matrix (CGM) dataset as reported in Wildenhain et al. (2015) Prediction of Synergism from Chemical-Genetic Interactions by Machine Learning. Cell Systems Volume 1, Issue 6, p383-395",Summary,,
497,1159580,2,1,,273003127,3048,Inactive,,,,,"The chemical genetic matrix (CGM) dataset as reported in Wildenhain et al. (2015) Prediction of Synergism from Chemical-Genetic Interactions by Machine Learning. Cell Systems Volume 1, Issue 6, p383-395",Summary,,
498,1159607,2,1,,312996170,3048,Inactive,,,,,Screen for inhibitors of RMI FANCM (MM2) intereaction,Other,26962873.0,
499,1259389,1,1,,124637242,3048,Inactive,,,,,HIV1_TAR : FRET assay measuring displacement of FAM and TAMRA-labeled Tat peptide from HIV-1 TAR RNA.,Screening,,
500,1259423,1,2,,354991233,3048,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
